Potential disease-modifying therapy for Parkinson’s disease
Drug Discovery World
NOVEMBER 28, 2023
Mission Therapeutics develops therapeutics that promote mitophagy, which enables the removal of dysfunctional mitochondria, thereby improving cell health and function. Parkinson’s disease is highly associated with mitochondrial dysfunction. By inhibiting USP30, MTX325 helps restore normal mitophagy and thus cellular health.
52 
Let's personalize your content